ANR.AX
Price:
$0.013
Market Cap:
$2.52M
Anatara Lifesciences Limited engages in the research, development, and commercializing of evidence-based solutions for gastrointestinal diseases in animals and humans in Australia. It offers Gastrointestinal ReProgramming, a proprietary formulation that combines bromelain with other evidence-based ingredients to address the primary underlying factors associated with human gastrointestinal conditions, such as irritable bowel syndrome and inflammatory bowel disease; and 3FDC for the treatment of anxiety, stress, or depression. The company also provides Detach for the treatment of diarrhea disease in piglets; BONIFF, a revised formulation to dry feed for piglets after weaning; and ANR-pf, a pro...[Read more]
Industry
Biotechnology
IPO Date
2014-10-15
Stock Exchange
ASX
Ticker
ANR.AX
According to Anatara Lifesciences Ltd’s latest financial reports and current stock price. The company's current PE Ratio is -1.30. This represents a change of -13.81% compared to the average of -1.51 of the last 4 quarters.
The mean historical PE Ratio of Anatara Lifesciences Ltd over the last ten years is -13.04. The current -1.30 PE Ratio has changed 897.04% with respect to the historical average. Over the past ten years (40 quarters), ANR.AX's PE Ratio was at its highest in in the June 2016 quarter at 34.35. The PE Ratio was at its lowest in in the December 2016 quarter at -29.32.
Average
-13.04
Median
-4.32
Minimum
-77.18
Maximum
-0.52
Discovering the peaks and valleys of Anatara Lifesciences Ltd PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 310.89%
Maximum Annual PE Ratio = -0.52
Minimum Annual Increase = -87.91%
Minimum Annual PE Ratio = -77.18
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -0.52 | -87.91% |
| 2024 | -4.33 | 219.51% |
| 2023 | -1.36 | -12.29% |
| 2022 | -1.55 | -68.27% |
| 2021 | -4.87 | 153.75% |
| 2020 | -1.92 | -55.44% |
| 2019 | -4.31 | -46.13% |
| 2018 | -8.00 | -69.66% |
| 2017 | -26.36 | -65.85% |
| 2016 | -77.18 | 310.89% |
The current PE Ratio of Anatara Lifesciences Ltd (ANR.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.07
5-year avg
-2.52
10-year avg
-13.04
Anatara Lifesciences Ltd’s PE Ratio is less than Elixinol Wellness Limited (-1.19), greater than Careteq Limited (-24.76), greater than Oakridge International Limited (-17.78), less than Osteopore Limited (-0.45), less than Zelira Therapeutics Limited (-1.09), less than AdAlta Limited (-0.54), less than Acrux Limited (-1.08), greater than Biotron Limited (-10.32), greater than TALi Digital Limited (-4.08), greater than Imagion Biosystems Limited (-1.91),
| Company | PE Ratio | Market cap |
|---|---|---|
| -1.19 | $2.39M | |
| -24.76 | $2.37M | |
| -17.78 | $2.27M | |
| -0.45 | $2.04M | |
| -1.09 | $4.05M | |
| -0.54 | $4.57M | |
| -1.08 | $6.57M | |
| -10.32 | $4.98M | |
| -4.08 | $3.74M | |
| -1.91 | $4.64M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Anatara Lifesciences Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Anatara Lifesciences Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Anatara Lifesciences Ltd's PE Ratio?
How is the PE Ratio calculated for Anatara Lifesciences Ltd (ANR.AX)?
What is the highest PE Ratio for Anatara Lifesciences Ltd (ANR.AX)?
What is the 3-year average PE Ratio for Anatara Lifesciences Ltd (ANR.AX)?
What is the 5-year average PE Ratio for Anatara Lifesciences Ltd (ANR.AX)?
How does the current PE Ratio for Anatara Lifesciences Ltd (ANR.AX) compare to its historical average?